DIgital Media briefs: March 2014

Share this article:
DIgital Media briefs: March 2014
DIgital Media briefs: March 2014

According to the IBM Digital Analytics Benchmark report, mobile traffic was up 40% compared to the fourth quarter of 2012, and accounted for nearly 35% of all online traffic. Smartphones drove 21.3% of all online traffic in 2013.

Canada's Office of the Privacy Commissioner investigated Google over targeted health ads. The Financial Post reports that the search engine violated the country's advertising rules when health service ads popped up on a user's screen after searching for sleep apnea devices. The commissioner says sleep apnea should have fallen under the “sensitive” category of search terms, which means advertisers should not be able to leverage that information for ads.

Glooko, a diabetes software company, with the Joslin Diabetes Center has agreed to co-develop a  “virtual Joslin” remote diabetes management platform. The platform will allow Joslin and other care teams to remotely monitor, coach and guide patients between in-clinic consulations.

Digital health startup Welltok said  that it had received $22.1 million in Series C funding from IBM and Qualcomm ­Ventures' life fund portfolio.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?